Skip to main content
SpringerLink
Log in

Anticonvulsants during Pregnancy and Lactation Transplacental, Maternal and Neonatal Pharmacokinetics

  • Research Review
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

Few data are available on placental transfer of anticonvulsants during early pregnancy. Nevertheless, it has been demonstrated that at this early stage of gestation, considerable amounts of Phenytoin, primidone/phenobarbitone and carbamazepine as well as some of their metabolites are already present in fetal tissues. Potentially reactive metabolites of anticonvulsants can be formed by the fetal liver and accumulate in some organs. At term, most anticonvulsants are present in neonatal plasma in concentrations similar to those in maternal plasma. Valproic acid, on the other hand, can accumulate in fetal blood, for still unknown reasons.

Elimination by the neonate is variable and is dependent on several factors, such as clinical state, pre- or perinatal enzyme induction, absorption of the drugs and their plasma protein binding. Neonatal acquisition of anticonvulsants via breast-feeding does not seem to be harmful for the neonate. In the case of phenobarbitone, however, the drug may accumulate in nursing neonates to levels approaching or even exceeding those of their mothers. Significant drug levels can also build up in neonates and infants nursed by carbamazepine-and ethosuximide-treated mothers.

This review contains relevant pharmacokinetic data on anticonvulsant drugs widely used during pregnancy and the neonatal period. The differences between pregnant and non-pregnant adults as well as between neonates and older age groups are emphasised. Some pharmacokinetic data are correlated with clinical manifestations, such as seizure frequency, neonatal depression and withdrawal symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alexander, F.W.: Sodium valproate and pregnancy. Archives of Disease in Childhood 54: 240–245 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Aymard, P.; Taburet, A.M.; Baudon, J.J.; Blanc, A.M:, Hervé, J. and Costil, J.: Kinetics and metabolism of phenobarbital in the neonate; in Johannessen (Ed.) Antiepileptic Therapy: Advances in Drug Monitoring, pp. 1–8 (Raven Press, New York 1980).

    Google Scholar 

  • Bardy, A.H.: Plasma clearances of Phenytoin, phenobarbitone, primidone and carbamazepine during pregnancy. A prospective study; in Janz et al. (Eds) Epilepsy, Pregnancy and the Child, pp. 141–145 (Raven Press, New York 1981).

    Google Scholar 

  • Baughman, F.A. and Randinitis, E.J.: Passage of diphenylhydantoin across the placenta. Journal of the American Medical Association 213: 466 (1970).

    Article  PubMed  Google Scholar 

  • Boreus, L.O.; Jailing, B. and Kallberg, N.: Clinical pharmacology of phenobarbital in the neonatal period; in Morselli et al. (Eds) Basic and Therapeutic Aspects of the Perinatal Pharmacology, pp.331–340 (Raven Press, New York 1975).

    Google Scholar 

  • Boréus, L.O.; Jalling, B. and Wallin A.: Plasma concentrations of phenobarbital in mother and child after combined prenatal and postnatal administration for prophylaxis of hyperbilirubinemia. Journal of Pediatrics 93: 695–698 (1978).

    Article  PubMed  Google Scholar 

  • Bossi, L.: Pharmacokinetics and clinical effects of anticonvulsant drugs in newborns; in Janz et al. (Eds) Epilepsy, Pregnancy and the Child pp.373–381 (Raven Press, New York 1981).

    Google Scholar 

  • Bossi, L.; Assael, B.M.; Avanzini, G.; Battino, D.; Caccamo, M.L.; Canger, R.; Como, M.L..; Pifarotti, G.; de Giambattista, M.; Franceschetti, S.; Marini, A.; Pardi, G.; Porro, M.G.; Rovei, V.; Sanjuan, M.; Soffientini, M.E.; Spina, S. and Spreafico, R.: Plasma levels and clinical effects of antiepileptic drugs in pregnant epileptic patients and their newborns; in Johannessen (Ed.) Antiepileptic Therapy: Advances in Drug Monitoring, pp.9–18 (Raven Press, New York 1980).

    Google Scholar 

  • Bowdle, T.A.; Indravadan, H.P.; Levy, R.H. and Wilensky, A.J.: Valproic acid dosage and plasma protein binding and clearance. Clinical Pharmacology and Therapeutics 28: 486–492 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Brachet-Liermain, A. and Demarquez, J.L.: Pharmacokinetics of dipropyl acetate in infants and young children. Pharmaceutisch Weekblad 112: 293–297 (1977).

    CAS  Google Scholar 

  • Brachet-Liermain, A.; Goutieres, F. and Aicardi, J.: Absorption of phenobarbital after the intramuscular administration of single doses in infants. Journal of Pediatrics 87: 624–626 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Canger, R.; Avanzini, G.; Battino, D.; Bossi, L.; Franceschetti, S. and Spina, S.: Modification of seizure frequency in pregnancy: prospective data in 48 patients with epilepsy; in Janz et al. (Eds) Epilepsy, Pregnancy and the Child pp.33–38 (Raven Press, New York 1981).

    Google Scholar 

  • Chiba, K.; Ishizaki, T.; Miura, H. and Minagawa, K.: Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age group. Journal of Pediatrics 96: 479–484 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Conney, A.H.: Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews 19: 317–366 (1967).

    PubMed  CAS  Google Scholar 

  • Conney, A.H.: Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews 19: 317–366 (1967).

    PubMed  CAS  Google Scholar 

  • Dam, M.; Christiansen, J.; Munck, O. and Mygind, K.I.: Antiepileptic drugs: metabolism in pregnancy. Clinical Pharmacokinetics 4: 53–62 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Davis, M.; Simmons, C.J.; Dordoni, B.; Maxwell, I.D. and Williams, R.: Induction of hepatic enzymes during normal human pregnancy. Journal of Obstetrics and Gynecology 80: 690–694 (1973).

    CAS  Google Scholar 

  • De Wolff, F.A.; Peters, A.C.B. and van Kempen, G.M.J.: Valproate induces urinary D-glucaric acid excretion. Lancet 1: 843 (1981).

    Article  PubMed  Google Scholar 

  • Dean, M.; Stock, B.; Patterson, R.J. and Levy, G.: Serum protein binding of drugs during and after pregnancy in humans. Clinical Pharmacology and Therapeutics 28: 253–261 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Dickinson, R.G.; Harland, R.C.; Lynn, R.K.; Smith, W.B. and Gerber, N.: Transmission of valproic acid (Dekapene) across the placenta: Half-life of the drug in mother and baby. Journal of Pediatrics 94: 832–835 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Dodson, W.E.: Nonlinear kinetics of phenytoin in children. Neurology 32: 42–48 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Eadie, M.J.; Lander, C.M. and Tyrer, J.H.: Plasma drug level monitoring in pregnancy. Clinical Pharmacokinetics 2: 427–436 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Egger, H.-J.; Wittfoht, W. and Nau, H.: Identification of diphenylhydantoin and its metabolites, including the dihydrodiol and the catechols in maternal plasma, placenta and fetal tissue of man; in Neubert et al. (Eds) Role of Pharmacokinetics in Prenatal and Perinatal Toxicology, pp.483–497 (Georg Thieme Publishers, Stuttgart 1978a).

    Google Scholar 

  • Egger, H.-J.; Wittfoht, W. and Nau, H.: Metabolism of diphenyl-hydantoin in isolated hepatocyte and liver organ cultures of the human fetus; in Neubert et al. (Eds) Role of Pharmacokinetics in Prenatal and Perinatal Toxicology, pp. 109–121 (Georg Thieme Publishers, Stuttgart 1978b).

    Google Scholar 

  • Egger, H.-J.; Wittfoht, W. and Nau, H.: Determination of diphenylhydantoin and its metabolites by glass capillary GC-MS. Advances in Mass Spectrometry 8: 1219–1226 (1980).

    Google Scholar 

  • Ehrnebo, M; Agurell, S.; Jailing, B. and Boreus, L.O.: Age differences in drug binding by plasma proteins: studies on human fetuses, neonates and adults. European Journal of Clinical Pharmacology 3: 189–193 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Eichelbaum, M.; Ekbom, K.; Bertilsson, L.; Ringberger, V.A. and Rane, A.: Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. European Journal of Clinical Pharmacology 8: 337–341 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Friis-Hansen, B.: Body water compartments in children: changes during growth and related changes in body composition. Pediatrics 28: 169–181 (1961).

    PubMed  CAS  Google Scholar 

  • Fröscher, W.; Niesen, M.; Altmann, D.; Eichelbaum, M; Gugler, R.; Hoffman, F. and Penin, H.: Antiepileptika-Therapie während der Schwangerschaft und Geburt; in Remschmidt et al. (Eds) Epilepsie 1980, pp. 152–163 (Georg Thieme Publishers, Stuttgart 1981).

    Google Scholar 

  • Glatt, H.R.; Oesch, F.; Frigerio, A. and Garattini, S.: Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. 1. Differences in mutagenicity. International Journal of Cancer 16: 787–797 (1975).

    Article  CAS  Google Scholar 

  • Gugler, R. and von Unruh, G.E.: Clinical pharmacokinetics of valproic acid. Clinical Pharmacokinetics 5: 67–83 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Hamar, C. and Levy, G.: Serum protein binding of drugs and bilirubin in newborn infants and their mothers. Clinical Pharmacology and Therapeutics 28: 58–63 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Heimann, G. and Gladtke, E.: Pharmacokinetics of phenobarbital in childhood. European Journal of Clinical Pharmacology 12: 305–310 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Helge, H. and Jäger, E.: Pharmacokinetics in the human neonate; in Neubert et al. (Eds) Role of Pharmacokinetics in Prenatal and Perinatal Toxicology, pp. 167–182 (Georg Thieme Publishers, Stuttgart 1978).

    Google Scholar 

  • Helge, H.; Gregg, B.; Jäger, E.; Knies, S.; Bochert, G. and Nigam, S.: N-demethylation of 13C-dimethylaminopyrine in children; in Klein et al. (Eds) Stable Isotopes: Proceedings of the Third International Conference pp.495–505 (Academic Press, New York 1979).

    Google Scholar 

  • Horning, M.G.; Butler, C.M.; Nowlin, J. and Hill, R.M.: Drug metabolism in the human neonate. Life Sciences 16: 651–672 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Ischizaki, T.; Yokochi, K.; Chiba, K.; Tabuchi, T. and T. Wagatsuma: Placental transfer of anticonvulsants (phenobarbital, Phenytoin, valproic acid) and the elimination from neonates. Pediatric Pharmacology 1: 291–303 (1981).

    Google Scholar 

  • Jailing, B.; Boréus, L.O.; Kallberg, N. and Agurell, S.: Disappearance from the newborn of circulating prenatally administered phenobarbital. European Journal of Clinical Pharmacology 6: 234–238 (1973).

    Article  Google Scholar 

  • Juchau, M.R.; Chao, S.T. and Omiecinski, C.J.: Drug metabolism by the human fetus. Clinical Pharmacokinetics 5: 320–339 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Kaneko, S.; Sato, T. and Suzuki, K.: The levels of anticonvulsants in breast milk. British Journal of Clinical Pharmacology 7: 624–626 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Kaneko, S.; Suzuki, K.; Sato, T.; Ogawa, Y. and Nomura, Y.: The problems of anticonvulsant medication at the neonatal period: Is breast feeding advisable? in Janz et al. (Eds) Epilepsy, Pregnancy and the Child, pp.343–347 (Raven Press, New York 1981).

    Google Scholar 

  • Kochenour, N.K.; Emlky, M.G. and Sawchuk, R.J.: Phenytoin metabolism in pregnancy. Obstetrics and Gynecology 56: 577–582 (1980).

    PubMed  CAS  Google Scholar 

  • Koup, J.R.; Rose, J.Q. and Cohen, M.E.: Ethosuximide pharmacokinetics in a pregnant patient and the newborn. Epilepsia 19: 535–539 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Krauer, B.; Krauer, F. and Hytten, F.E.: Drug disposition and pharmacokinetics in the maternal placental fetal unit. Pharmacology and Therapeutics 10: 301–328 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Kurz, H.; Mauser-Ganshorn, A. and Stickel, H.H.: Differences in the binding of drugs to plasma proteins from newborn and adult man. I. European Journal of Clinical Pharmacology 11: 463–467 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Lander, C.M.; Edwards, V.E.; Eadie, M.J. and Tyrer, J.H.: Plasma anticonvulsant concentrations during pregnancy. Neurology 27: 128–131 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Landon, M.J. and Kirkley, M.: Metabolism of diphenylhydantoin (Phenytoin) during pregnancy. British Journal of Obstetrics and Gynaecology 86: 125–132 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Liddiard, C.; Brendel, K. and Nau, H.: Drug metabolism in cultures of isolated hepatocytes of the human fetus, the newborn pig and the adult rat; in Neubert et al. (Eds) Role of Pharmacokinetics in Prenatal and Perinatal Toxicology, pp.91–108 (Georg Thieme Publishers, Stuttgart 1978).

    Google Scholar 

  • Liddiard, C.; Merker, H.-J. and Nau, H.: An improved method for the preparation of human fetal and adult hepatocytes. Advances in Toxicology 44: 107–112 (1980).

    Article  CAS  Google Scholar 

  • Loughnan, P.M.; Greenwald, A.; Purton, W.W.; Aranda, J.V.; Watters, G. and Neims, A.H.: Pharmacokinetic observations of Phenytoin disposition in the newborn and young infant. Archives of Disease in Childhood 52: 302–309 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Martinez, G. and Snyder, R.D.: Transplacental passage of primidone. Neurology 23: 381–383 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Melchior, J.C.; Svensmark, O. and Trolle, D.: Placental transfer of phenobarbitone in epileptic women, and elimination in newborns. Lancet 2: 860–861 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Mirkin, B.L.: Placental transfer and neonatal elimination of diphenylhydantoin. American Journal of Obstetrics and Gynecology 109: 930–933 (1971a).

    PubMed  CAS  Google Scholar 

  • Mirkin, B.L.: Diphenylhydantoin: Placental transport, fetal localization, neonatal metabolism, and possible teratogenic effects. Pediatric Pharmacology and Therapeutics 78: 329–337 (1971b).

    CAS  Google Scholar 

  • Morselli, P.L.: Clinical pharmacokinetics in neonates. Clinical Pharmacokinetics 1(2): 81–98 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Morselli, P.L.: Antiepileptic drugs; in Morselli (Ed.) Drug Disposition During Development, pp.311–360 (Spectrum Publications, New York 1977).

    Google Scholar 

  • Morselli, P.L. and Francc-Morselli, R.: Clinical pharmacokinetics of antiepileptic drugs in adults. Pharmacological Therapeutics 10: 65–101 (1980).

    Article  CAS  Google Scholar 

  • Morselli, P.L.; Franco-Morselli, R. and Bossi, L.: Clinical pharmacokinetics in newborns and infants. Clinical Pharmacokinetics 5: 485–527 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Mygind, K.I.; Dam, M. and Christiansen, J.: Phenytoin and phenobarbitone plasma clearance during pregnancy. Acta Neurologica Scandinavica 54: 160–166 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Nau, H. and Liddiard, C.: Liver organ culture as a long term viable system for the study of drug metabolism in the human fetus; in Neubert et al. (Eds) Role of Pharmacokinetics in Prenatal and Perinatal Toxicology, pp.77–90 (Georg Thieme Publishers, Stuttgart 1978).

    Google Scholar 

  • Nau, H.; Liddiard, C; Egger, H.-J. and Wittfoht, W.: Drug metabolism and lipid peroxidation in various hepatic in vitro systems of the human fetus; in Olive (Ed.) Advances in Pharmacology and Therapeutics 8, pp.91–100 (Pergamon Press, Oxford and New York 1978).

    Google Scholar 

  • Nau, H.; Rating, D.; Häuser, I.; Jäger, E.; Koch, S. and Helge, H.: Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers. European Journal of Clinical Pharmacology 18: 31–42 (1980a).

    Article  PubMed  CAS  Google Scholar 

  • Nau, H. and Neubert, D.: Development of drug-metabolizing monooxygenase systems in various mammalian species including man. Its significance for transplacental toxicity; in Neubert et al. (Eds) Role of Pharmacokinetics in Prenatal and Perinatal Toxicology, pp. 13–44 (Georg Thieme Publishers, Stuttgart 1980b).

    Google Scholar 

  • Nau, H.; Schmidt, D.; Beck-Mannagetta, G.; Rating, D.; Koch, S. and Helge, H.: Pharmacokinetics of primidone and metabolites during human pregnancy; in Janz et al. (Eds) Epilepsy, Pregnancy and the Child, pp. 121–130 (Raven Press, New York 1981a).

    Google Scholar 

  • Nau, H.; Rating, D.; Häuser, I.; Jäger, E.; Göpfert-Geyer, I. and Helge, H.: Placental transfer at birth and postnatal elimination of primidone and metabolites in neonates of epileptic mothers; in Janz et al. (Eds) Epilepsy, Pregnancy and the Child, pp.361–366 (Raven Press, New York 1981b).

    Google Scholar 

  • Nau, H.; Wittfoht, W.; Rating, D.; Jakobs, C.; Schäfer, H. and Helge, H.: Pharmacokinetics of valproic acid and its metabolites in a pregnant patient: stable isotope methodology; in Janz et al. (Eds) Epilepsy, Pregnancy and the Child, pp. 131–144 (Raven Press, New York 1981c).

    Google Scholar 

  • Nau, H.; Rating, D.; Koch, S.; Häuser, I. and Helge, H.: Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother’s milk and clinical status in neonates of epileptic mothers. Journal of Pharmacology and Experimental Therapeutics 219: 768–777 (1981d).

    PubMed  CAS  Google Scholar 

  • Nau, H.; Schäfer, H.; Rating, D.; Jakobs, C. and Helge, H.: Placental transfer and neonatal pharmacokinetics of valproic acid and some of its metabolites; in Janz et al. (Eds) Epilepsy, Pregnancy and the Child, pp.367–372 (Raven Press, New York 1981e).

    Google Scholar 

  • Nau, H.; Wittfoht, W.; Schäfer, H.; Jakobs, C. and Helge, H.: Valproic acid and several metabolites: quantitative determination in serum, urine, breast milk and tissues by GC-MS selected ion monitoring. Journal of Chromatography 226: 69–78 (1981f).

    Article  PubMed  CAS  Google Scholar 

  • Niebyl, J.R.; Blake, D.A.; Freeman, J.M. and Luff, R.D.: Carbamazepine levels in pregnancy and lactation. Obstetrics and Gynecology 53: 139–140 (1979).

    PubMed  CAS  Google Scholar 

  • Painter, M.J.; Pippenger, C.; MacDonald, H. and Pitlick, W.: Phenobarbital and diphenylhydantoin levels in neonates with seizures. Journal of Pediatrics 92: 315–319 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Pelkonen, O.: Biotransformation of xenobiotics in the fetus. Pharmacological Therapeutics 10: 261–281 (1980).

    Article  CAS  Google Scholar 

  • Perez, V.; Gorodisch, S.; Casavilla, F. and Maruffo, C: Ultra-structure of human liver at the end of normal pregnancy. American Journal of Obstetrics and Gynecology 110: 428–431 (1971).

    PubMed  CAS  Google Scholar 

  • Persson, B.H.: Studies on the accumulation of certain barbiturates in the brain of the human fetus. Acta Obstetrica Gynecologica Scandinavica 39: 88–99 (1960).

    Article  CAS  Google Scholar 

  • Perucca, E.; Ruprah, M. and Richens, A.: Altered drug binding to serum proteins in pregnant women: therapeutic relevance. Journal of the Royal Society of Medicine 74: 422–426 (1981).

    PubMed  CAS  Google Scholar 

  • Philbert, A. and Dam, M.: The epileptic mother and her child. Epilepsia 23: 85–99 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Philbert, A.; Dam, M. and Pedersen, B.: Serum levels of valproic acid during pregnancy. Scandinavian Epilepsy Conference (1981).

  • Piafsky, K.M. and Rane, A.: Formation of carbamazepine epoxide in human fetal liver. Drug Metabolism and Disposition 6: 502 (1978).

    PubMed  CAS  Google Scholar 

  • Pitlick, W.; Painter, M. and Pippenger, C.: Phenobarbital pharmacokinetics in neonates. Clinical Pharmacology and Therapeutics 23: 346–350 (1978).

    PubMed  CAS  Google Scholar 

  • Plasse, J.C.; Revol, M.; Chabert, G. and Ducerf, F.: Neonatal pharmacokinetics of valproic acid; in Schaaf and van der Kleijn (Eds) Progress in Clinical Pharmacy, pp.247–252 (Elsevier North Holland, Amsterdam 1979).

    Google Scholar 

  • Plomann, L. and Persson, B.H.: On the transfer of barbiturates to the human fetus and their accumulation in some of its vital organs. Journal of Obstetrics and Gynecology 64: 706–711 (1957).

    Google Scholar 

  • Pynnönen, S.; Kanto, J.; Sillanpää, M. and Erkkola, R.: Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacologica et Toxicologica 41: 244–253 (1977).

    Article  PubMed  Google Scholar 

  • Ramsay, R.E.; Strauss, R.G.; Wilder, J. and Willmore, J.: Status epilepticus in pregnancy: effect of Phenytoin malabsorption on seizure control. Neurology 28: 85–96 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Rane, A.: Urinary excretion of diphenylhydantoin metabolites in newborn infants. Journal of Pediatrics 85: 543–545 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Rane, A.; Bertilsson, L. and Palmer, L.: Disposition of placentally transferred carbamazepine (Tegretol) in the newborn. European Journal of Clinical Pharmacology 8: 283–284 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Rane, A.; Garle, M.; Borgå, O. and Sjöqvist, F.: Plasma disappearance of transplacentaly transferred diphenylhydantoin in the newborn studied by mass fragmentography. Clinical Pharmacology and Therapeutics 15: 39–45 (1974).

    PubMed  CAS  Google Scholar 

  • Rane, A.; Hoppel, C. and Hojer, B.: Kinetics of placentally transferred Phenytoin and its p-hydroxylated metabolites in newborn infants. British Journal of Clinical Pharmacology 8: 465–468 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Rane, A.; Lunde, P.K.M.; Jalling, B.; Yaffe, S.J. and Sjöqvist, F.: Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants. Journal of Pediatrics 78: 877–882 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Rane, A.; Sundwall, A. and Tomson, G.: Oxidative and synthetic drug-metabolic pathways in the newborn infant. Studies on the neonatal kinetics of oxazepam; In Neubert et al. (Eds) Role of Pharmacokinetics in Prenatal and Perinatal Toxicology, pp. 183–191 (Georg Thieme Publishers, Stuttgart 1978).

    Google Scholar 

  • Rane, A. and Tunell, R.: Ethosuximide in human milk and in plasma of a mother and her nursed infant. British Journal of Clinical Pharmacology 12: 855–858 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Rating, D.; Jäger-Roman, E.; Koch, S.; Nau, H. and Helge, H.: Enzyme induction in neonates due to antiepileptic therapy during pregnancy; in Janz et al. (Eds) Epilepsy, Pregnancy and the Child, pp.349–355 (Raven Press, New York 1981a).

    Google Scholar 

  • Rating, D.; Jäger-Roman, G.; Koch, S.; Nau, H.; Klein, P.D. and Helge, H.: Minor anomalies in the offspring of epileptic parents (prospective study); in Janz et al. (Eds) Epilep’sy, Pregnancy and the Child, pp.282–288 (Raven Press, New York 1981b).

    Google Scholar 

  • Rating, D.; Nau, H.; Jäger-Roman, E.; Göpfert-Geyer, I.; Koch, S.; Beck-Mannagetta, G.; Schmidt, D. and Helge, H.: Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women. Acta Paediatrica Scandinavica 71: 301–311 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Reith, A. and Schäfer, H.: Antiepileptika Während Schwangerschaft und Stillzeit. Deutsche Medizinsche Wochenschrift 104: 818–823 (1979).

    Article  CAS  Google Scholar 

  • Rey, E.; D’Athis, P.; de Lauture, D.; Dulac, O.; Aicardi, J. and Olive, G.: Pharmacokinetics of carbamazepine in the neonate and in the child. International Journal of Clinical Pharmacology and Biopharmacology 17: 90–96 (1979).

    CAS  Google Scholar 

  • Reynolds, J.W. and Mirkin, B.L.: Urinary corticosteroid and diphenylhydantoin metabolite patterns in neonates exposed to anticonvulsant drugs in utero. Clinical Pharmacology and Therapeutics 14: 891–897 (1973).

    PubMed  CAS  Google Scholar 

  • Ruprah, M.; Perucca, E. and Richens, A.: Phenytoin binding in pregnancy. Lancet 1: 97 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Schmidt, D.: The effect of pregnancy on the natural history of epilepsy; in Janz et al. (Eds) Epilepsy, Pregnancy and the Child, pp.39–49 (Raven Press, New York 1981).

    Google Scholar 

  • Similä, S.; von Wendt, L.; Hartikainen-Sorri, A.-L.; Kääpä, P. and Sankkonen, A.-L.: Sodium valproate, pregnancy and neonatal hyperglycinaemia. Archives of the Disabled Child 54: 985–986 (1979).

    Article  Google Scholar 

  • Spielberg, S.P.; Gordon, G.B.; Blake, D.A.; Meilits, E.D. and Brass, D.S.: Anticonvulsant toxicity in vitro; possible role of arene oxides. Journal of Pharmacology and Experimental Therapeutics 217: 386–389 (1981).

    PubMed  CAS  Google Scholar 

  • Stock, B.H.: Drug disposition in pregnancy. Pharmacy International 2: 60–63 (1981).

    CAS  Google Scholar 

  • Urein, S.; Albengers, E. and Tillement, J.-P.: Serum protein binding of valproic acid in healthy subjects and patients with liver disease. International Journal of Clinical Pharmacology, Therapy and Toxicology 19: 319–325 (1981).

    Google Scholar 

  • Van der Kleijn, E.; Vree, T.B.; Guelen, P.; Schobten, F.; Westenberg, H. and Knop, H.: Kinetics of drug interactions in the treatment of epilepsy; in Meinardi (Ed.) Advances in Epileptology —1977, pp. 197–210 (Swets and Zeitlinger Verlag, Amsterdam 1978).

    Google Scholar 

  • Windorfer, A.: Stillen und Medikamente. Medizinische Monatszeitschrift für Pharmazie 7: 193–198 (1979).

    Google Scholar 

  • Wittfoht, W.; Nau, H., Rating, D. and Helge, H.: 13C-labelled valproic acid pulse dosing during steady state antiepileptic therapy for pharmacokinetic studies during pregnancy; in Schmidt et al. (Eds) Stable Isotopes, pp.265–270 (Elselvier, Amsterdam 1982).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Toxikologie und Embryonalpharmakologie and Kinderklinik, Freie Universität Berlin, Garystrasse 9, D-1000, Berlin 33, West Germany

    H. Nau, W. Kuhnz, H.-J. Egger, D. Rating & H. Helge

  2. Hoffmann La Roche, Basel, Switzerland

    H. Nau, W. Kuhnz, H.-J. Egger, D. Rating & H. Helge

Authors
  1. H. Nau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Kuhnz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H.-J. Egger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Rating
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Helge
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nau, H., Kuhnz, W., Egger, HJ. et al. Anticonvulsants during Pregnancy and Lactation Transplacental, Maternal and Neonatal Pharmacokinetics. Clin Pharmacokinet 7, 508–543 (1982). https://doi.org/10.2165/00003088-198207060-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198207060-00003

Keywords

Search

Navigation